Related references
Note: Only part of the references are listed.Monoclonal antibodies against metzincin targets
Salvatore Santamaria et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue
Elizabeth A. Loughran et al.
NEOPLASIA (2018)
With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment
Elizabeth I. Harper et al.
CANCERS (2018)
Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics
Jing Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis
Y. Klymenko et al.
ONCOGENE (2017)
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
Marina Rosso et al.
PLOS ONE (2017)
PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
Kholoud Alwosaibai et al.
ONCOTARGET (2017)
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
Y. Zhang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Anti-angiogenic agents in ovarian cancer: past, present, and future
B. J. Monk et al.
ANNALS OF ONCOLOGY (2016)
Tumor microenvironment: The culprit for ovarian cancer metastasis?
Zhongyue Luo et al.
CANCER LETTERS (2016)
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Agata Jablonska-Trypuc et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts
Michael J. Tisza et al.
ONCOTARGET (2016)
Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes
Anuradha Moirangthem et al.
SCIENTIFIC REPORTS (2016)
Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
Eleanor I. Ager et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature
Elena I. Deryugina et al.
MATRIX BIOLOGY (2015)
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
A. K. Mitra et al.
ONCOGENE (2015)
Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT
Wenfeng Li et al.
TUMOR BIOLOGY (2015)
Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
Eleanor I. Ager et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Ovarian cancer: involvement of the matrix metalloproteinases
Linah Al-Alem et al.
REPRODUCTION (2015)
Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium
Lana Bruney et al.
BIOLOGICAL CHEMISTRY (2014)
A novel β-catenin signaling pathway activated by IL-1β leads to the onset of epithelial-mesenchymal transition in breast cancer cells
Eloy Andres Perez-Yepez et al.
CANCER LETTERS (2014)
Modeling Persistence in Mesenchymal Cell Motility Using Explicit Fibers
David Lepzelter et al.
LANGMUIR (2014)
Epithelial ovarian cancer experimental models
E. Lengyel et al.
ONCOGENE (2014)
Selective Blockade of Matrix Metalloprotease-14 with a Monoclonal Antibody Abrogates Invasion, Angiogenesis, and Tumor Growth in Ovarian Cancer
Rajani Kaimal et al.
CANCER RESEARCH (2013)
SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain
Shubha Murthy et al.
BIOCHEMICAL JOURNAL (2012)
Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme
Elena I. Deryugina et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Song Yi Ko et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Matrix metalloproteinase-2 Promotes αvβ3 Integrin-Mediated Adhesion and Migration of Human Melanoma Cells by Cleaving Fibronectin
Yang Jiao et al.
PLOS ONE (2012)
Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients
Susan K. Lutgendorf et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition
Chun-Yu Lin et al.
CANCER SCIENCE (2011)
Protein myozap - a late addition to the molecular ensembles of various kinds of adherens junctions
Steffen Rickelt et al.
CELL AND TISSUE RESEARCH (2011)
Matrix metalloproteinases in tumorigenesis: an evolving paradigm
Hui Hua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
Catherine Theriault et al.
GYNECOLOGIC ONCOLOGY (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration
Estefania Ugarte-Berzal et al.
BLOOD (2010)
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
Sven Mahner et al.
BMC CANCER (2010)
MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells
Chandramu Chetty et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Ouabain modulates epithelial cell tight junction
Isabel Larre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
Natalie M. Moss et al.
CANCER RESEARCH (2009)
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Laetitia Devy et al.
CANCER RESEARCH (2009)
MMP-2 functions as an early response protein in ovarian cancer metastasis
Hilary A. Kenny et al.
CELL CYCLE (2009)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients
Li Wang et al.
GYNECOLOGIC ONCOLOGY (2009)
Modulation of the Membrane Type 1 Matrix Metalloproteinase Cytoplasmic Tail Enhances Tumor Cell Invasion and Proliferation in Three-dimensional Collagen Matrices
Natalie M. Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Matrix-Degrading Metalloproteinases in Photoaging
Taihao Quan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2009)
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer
X-F Li et al.
ONCOGENE (2009)
Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma
Susan K. Lutgendorf et al.
CLINICAL CANCER RESEARCH (2008)
Proteases: Multifunctional Enzymes in Life and Disease
Carlos Lopez-Otin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with β1 integrins
Chi-Hui Tang et al.
JOURNAL OF CELL SCIENCE (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion
Dorina Belotti et al.
MOLECULAR CANCER RESEARCH (2008)
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum
Hilary A. Kenny et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
MTI-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells
K. L. Sodek et al.
BRITISH JOURNAL OF CANCER (2007)
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells
Jaime Symowicz et al.
CANCER RESEARCH (2007)
Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression
Maria V. Barbolina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells
Eric V. Yang et al.
CANCER RESEARCH (2006)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker et al.
NATURE MEDICINE (2006)
Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells
E McNeil et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer
WJ Lubbe et al.
CLINICAL CANCER RESEARCH (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Stress hormone-mediated invasion of ovarian cancer cells
AK Sood et al.
CLINICAL CANCER RESEARCH (2006)
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
DC Radisky et al.
NATURE (2005)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells
G Villegas et al.
KIDNEY INTERNATIONAL (2005)
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation
S Parrinello et al.
JOURNAL OF CELL SCIENCE (2005)
E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases
XL Qian et al.
EMBO JOURNAL (2004)
Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases
NE Sounni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells
A Miyoshi et al.
BRITISH JOURNAL OF CANCER (2004)
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
A Rump et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
N Nishida et al.
CANCER (2004)
The urokinase plasminogen activator system: Role in malignancy
MJ Duffy
CURRENT PHARMACEUTICAL DESIGN (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells
TL Drell et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Stress-related modulation of matrix metalloproteinase expression
EV Yang et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Vascular endothelial growth factor and social support in patients with ovarian carcinoma
SK Lutgendorf et al.
CANCER (2002)
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression
NE Sounni et al.
FASEB JOURNAL (2002)
Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo
JS Xu et al.
JOURNAL OF CELL BIOLOGY (2001)
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer
E Lengyel et al.
GYNECOLOGIC ONCOLOGY (2001)
Functional interplay between type I collagen and cell surface matrix metalloproteinase activity
SM Ellerbroek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Release of norepinephrine from human ovary - Coupling to steroidogenic response
HE Lara et al.
ENDOCRINE (2001)
Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen
M Seandel et al.
BLOOD (2001)
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-β
GC Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Role of vascular endothelial growth factor in ovarian physiology and pathology
E Geva et al.
FERTILITY AND STERILITY (2000)
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
ZJ Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
JM Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Truncation of the β-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution
CJ Vallorosi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Matrix metalloproteinases: Biologic activity and clinical implications
AR Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
